Pain
From the Journals
Intramuscular steroid injection reduced hip OA pain up to 12 weeks
Results at 12 weeks called surprising.
Conference Coverage
The case for being open-minded about medical marijuana
LAS VEGAS – As part of an open approach, educate patients about effective alternative treatments to medical cannabis, an expert advises.
Feature
Opioid prescriptions got shorter in 2017
Pharmacy benefits manager reports increased use of drugs to treat opioid dependence.
From the Journals
Nonopioid analgesics have no major disadvantages vs. opioids for chronic pain
Chronic pain patients may be able to improve function without increasing risk of addiction.
News
FDA alerts doctors to stop administering compounded products
Patients could be at risk for serious harms if they receive drugs manufactured by this company.
Conference Coverage
Experts review the year in rheumatology ... and what lies ahead
Thought leaders pick rheumatology’s top developments in the past year and predict the big events to come at the Rheumatology Winter Clinical...
From the Journals
Turmeric-, frankincense-derived supplement shows OA benefit
The combination beat placebo in a randomized, controlled trial from Armenia.
From the Journals
Novel herpes zoster vaccine is more cost effective than old vaccine
Cost-effectiveness can be an important factor in considering patient treatment for herpes zoster.
Conference Coverage
Virtual reality enters the rheumatology realm
SAN DIEGO – New feasibility study aims to understand its potential for pain.
News
New buprenorphine formulation approved for medication-assisted treatment
Patients who are currently taking other buprenorphine formulations can be transitioned.
Latest News
CMS to enlist Medicare Part D plans to combat opioid abuse
Officials would like to extend the use the criteria for overutilizers to identify at-risk beneficiaries, then allow insurers to limit their access...